The FMS-like tyrosine kinase 3 (FLT3) also known as cluster of differentiation antigen 135 (CD135) or fetal liver kinase-2 (Flk2) is a class III receptor tyrosine kinase (RTK) that plays a key role in controlling survival, proliferation, and differentiation of hematopoietic cells and it widely expresses in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Mutations in FLT3 (both internal tandem duplications (ITD) and point mutations) are among the most common somatic mutations in AML patients and are associated with poor prognosis and outcome in those patients.
| Product Name | Catalog # | Price (FP)* | Catalog # | Price (NP)** | Qty | |
|---|---|---|---|---|---|---|
| FLT3 D835Y Stably expressing Ba/F3 Cell Line | SL-0113-FP | $3,870 | SL-0113-NP | $1,973 | ||
| FLT3 D835V Stably expressing Ba/F3 Cell Line | SL-0114-FP | $3,870 | SL-0114-NP | $1,973 | ||
| FLT3 D835E Stably expressing Ba/F3 Cell Line | SL-0115-FP | $3,870 | SL-0115-NP | $1,973 | ||
| FLT3 D835N Stably expressing Ba/F3 Cell Line | SL-0116-FP | $3,870 | SL-0116-NP | $1,973 | ||
| FLT3 D835F Stably expressing Ba/F3 Cell Line | SL-0117-FP | $3,870 | SL-0117-NP | $1,973 | ||
| FLT3 D835H Stably expressing Ba/F3 Cell Line | SL-0118-FP | $3,870 | SL-0118-NP | $1,973 | ||
| FLT3 WT Stably expressing Ba/F3 Cell Line | SL-0119-FP | $3,870 | SL-0119-NP | $1,973 |
- * For Profit (FP) price is for non-academic, private companies and institutes
- ** Non Profit (NP) price is for academic, non profit organizations and institutes
